LEANDRA OGAS: Open Payments
NPI 1043766249 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 30 payments from 11 companies in 2025. Trend: 2023 $417 · 2024 $535 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $262 |
| Globus Medical, Inc. | 1 | $146 |
| Amgen Inc. | 1 | $83 |
| Novo Nordisk Inc | 3 | $58 |
| Exact Sciences Corporation | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Lilly USA, LLC | 3 | $48 |
| PFIZER INC. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: AIRSUPRA, Senza, REPATHA, The Cologuard Plus Collection Kit, MOUNJARO, PAXLOVID, BREZTRI, Sunosi.
Industry payments across NM — which companies pay providers there.
